These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Kang CD, Ahn BK, Jeong CS, Kim KW, Lee HJ, Yoo SD, Chung BS, Kim SH. Exp Cell Res; 2000 Apr 10; 256(1):300-7. PubMed ID: 10739677 [Abstract] [Full Text] [Related]
24. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure. He H, Lyons KA, Shen X, Yao Z, Bleasby K, Chan G, Hafey M, Li X, Xu S, Salituro GM, Cohen LH, Tang W. Xenobiotica; 2009 Sep 10; 39(9):687-93. PubMed ID: 19569734 [Abstract] [Full Text] [Related]
26. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity. Dyszlewski M, Blake HM, Dahlheimer JL, Pica CM, Piwnica-Worms D. Mol Imaging; 2002 Sep 10; 1(1):24-35. PubMed ID: 12920858 [Abstract] [Full Text] [Related]
27. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska L, Balkay L, Mikecz P, Trón L, Krasznai Z. Eur J Nucl Med Mol Imaging; 2003 Aug 10; 30(8):1147-54. PubMed ID: 12830325 [Abstract] [Full Text] [Related]
28. (67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity. Sivapackiam J, Harpstrite SE, Prior JL, Mattingly S, Sharma V. Nucl Med Biol; 2016 Mar 10; 43(3):191-7. PubMed ID: 26924499 [Abstract] [Full Text] [Related]
29. Interrogation of multidrug resistance (MDR1) P-glycoprotein (ABCB1) expression in human pancreatic carcinoma cells: correlation of 99mTc-Sestamibi uptake with western blot analysis. Harpstrite SE, Gu H, Natarajan R, Sharma V. Nucl Med Commun; 2014 Oct 10; 35(10):1067-70. PubMed ID: 25036383 [Abstract] [Full Text] [Related]
30. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators. Shen X, Chen G, Zhu G, Cai J, Wang L, Hu Y, Fong WF. J Pharm Pharmacol; 2012 Jan 10; 64(1):90-100. PubMed ID: 22150676 [Abstract] [Full Text] [Related]
31. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals. Piwnica-Worms D, Sharma V. Curr Top Med Chem; 2010 Jan 10; 10(17):1834-45. PubMed ID: 20645914 [Abstract] [Full Text] [Related]
32. Antisense targeting of p-glycoprotein expression in tissue culture. Nakamura K, Kubo A, Hnatowich DJ. J Nucl Med; 2005 Mar 10; 46(3):509-13. PubMed ID: 15750166 [Abstract] [Full Text] [Related]
33. Single photon emission computed tomography and positron emission tomography imaging of multi-drug resistant P-glycoprotein--monitoring a transport activity important in cancer, blood-brain barrier function and Alzheimer's disease. Piwnica-Worms D, Kesarwala AH, Pichler A, Prior JL, Sharma V. Neuroimaging Clin N Am; 2006 Nov 10; 16(4):575-89, viii. PubMed ID: 17148020 [Abstract] [Full Text] [Related]
34. Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe. Wang M, Mao C, Wang H, Ling X, Wu Z, Li Z, Ming X. Mol Pharm; 2017 Oct 02; 14(10):3391-3398. PubMed ID: 28813596 [Abstract] [Full Text] [Related]
35. Detection of the MDR1 P-glycoprotein expression and function. Mechetner E. Methods Mol Biol; 2007 Oct 02; 378():175-93. PubMed ID: 18605086 [Abstract] [Full Text] [Related]
36. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors. Eckford PD, Sharom FJ. Biochem Cell Biol; 2006 Dec 02; 84(6):1022-33. PubMed ID: 17215888 [Abstract] [Full Text] [Related]
37. Synthesis, characterization, and molecular structure of a novel zinc (II) complex: assessment of impact of MDR1Pgp expression on its cytotoxic activity. Harpstrite SE, Prior JL, Sivapackiam J, Collins SD, Rath NP, Sharma V. Med Chem; 2010 Jul 02; 6(4):191-9. PubMed ID: 20843281 [Abstract] [Full Text] [Related]
38. Radiosynthesis and biological evaluation of 68Ga-labeled colchicine conjugates. Satpati D, Korde A, Sarma HD, Banerjee S. Cancer Biother Radiopharm; 2014 Aug 02; 29(6):251-6. PubMed ID: 24983126 [Abstract] [Full Text] [Related]
39. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. Zhang C, Zuo Z, Kwan P, Baum L. Epilepsia; 2011 Oct 02; 52(10):1894-904. PubMed ID: 21692796 [Abstract] [Full Text] [Related]
40. Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells. Dupuis ML, Ascione A, Palmisano L, Vella S, Cianfriglia M. BMC Pharmacol Toxicol; 2013 Sep 20; 14():47. PubMed ID: 24053678 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]